May 6, 2010 – Peripheral and Central Nervous System Drugs Advisory Committee
sNDA – ACTHAR Gel (Questcor)
Agenda: On May 6, 2010, the committee will discuss supplemental new drug application (sNDA) 22-432, H.P. ACTHAR Gel (repository corticotropin injection), 80 USP units per milliliter, Questcor Pharmaceuticals, proposed for the treatment of infantile spasms.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment